Pharmacokinetic and pharmacodynamic modeling of cetrorelix, an LH-RH antagonist, after subcutaneous administration in healthy premenopausal women

Clinical Pharmacology and Therapeutics

Volumn 68, Issue 6, 2000, Pages 617-625

  Nagaraja, Nelamangala V ^a,b,c   Pechstein, Birgit ^a,b,c   Erb, Katharina ^a,b,c   Klipping, Christine ^a,b,c   Hermann, Robert ^a,b,c   Niebch, Georg ^a,b,c   Derendorf, Hartmut ^a,b,c  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b ASTA MEDICA AG   (Germany)

^c Medical Investigations   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; GONADORELIN ANTAGONIST; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHEMOLUMINESCENCE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; FOLLITROPIN RELEASE; HORMONAL THERAPY; HUMAN; HUMAN EXPERIMENT; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MENSTRUAL CYCLE; OVULATION INHIBITION; PREMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL;

ADULT; BODY FLUID COMPARTMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INJECTIONS, SUBCUTANEOUS; LUTEINIZING HORMONE; MATHEMATICAL COMPUTING; MODELS, BIOLOGICAL; PREMENOPAUSE; PROGESTERONE; SINGLE-BLIND METHOD;

EID: 0034525445     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.111481     Document Type: Article

References (23)

1. Cetrorelix
2. Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist cetrorelix in healthy female volunteers
3. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist cetrorelix during ovarian stimulation
4. A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (cetrorelix) postpones the luteinizing hormone (LH) surge: Further evidence for the role of GnRH during the LH surge
5. Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)antagonist cetrorelix at different dosages
6. The use of a GnRH antagonist (cetrorelix) in a single dose protocol in IVF-embryo transfer: A dose finding study of 3 versus 2 mg
7. Development of radioimmunoassay for a potent luteinizing hormone-releasing hormone antagonist: Evaluation of serum levels after injection of [Ac-3-(2-naphthyl)-D-Ala1, D-Phe(pCl)2, 3-(3-pyridyl)-D- Ala3, D-Cit6, D-Ala10] LHRH
8. Effects on pituitary and gonadal hormones and ovulation as well as noncompartmental pharmacokinetics of single subcutaneous doses of cetrorelix acetate in a placebo-controlled study in healthy premenopausal women
9. Comparison of four basic models of indirect pharmacodynamic responses
10. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)
11. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: A prospective uncontrolled phase III study
12. Pharmacokinetic-pharmacodynamic modeling of testosterone and luteinizing hormone suppression by cetrorelix in healthy volunteers
13. Seven-day administration of the gonadotropin-releasing hormone antagonist cetrorelix in normal cycling women
14. Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women
15. Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model
16. Gonadotropin-releasing hormone requirements for ovulation
17. Contemporary aspects of discrete peak detection algorithms; I: The paradigm of the luteinizing hormone pulse signal in men
18. A novel general biophysical model for simulating episodic endocrine gland signaling
19. The pituitary gland secretes in bursts: Appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations
20. Evaluation of pulse-detection algorithms by computer simulation of hormone secretion
21. Reanalysis of the rat proestrous LH surge by deconvolution analysis
22. A model of follicular development and ovulation in sheep and cattle
23. Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide